Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.25 +0.20 (+1.66%)
Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
50 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. 
Via Benzinga
News headline image
Recap: Amarin Corp Q1 Earnings ↗
Amarin Corp (NASDAQ:AMRN) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2022 ↗
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points ↗
U.S. stocks traded mixed this morning, with the Nasdaq dropping more than 100 points on Wednesday. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Amarin Corp's Earnings: A Preview ↗
Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
News headline image
NASDAQ:AMRN Long Term Investor Notice: Investigation of Potential Wrongdoing at Amarin Corporation Plc ↗
San Diego, CA -- (SBWIRE) -- 03/09/2022 -- An investigation was announced for investors in shares of Amarin Corporation plc (NASDAQ:AMRN) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
News headline image
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
Via Benzinga
News headline image
Lower Vascepa Volume Hits Amarin's Q4 Topline Growth ↗
Amarin Corp plc's (NASDAQ: AMRN) Q4 FY21 sales decreased 13.6% Y/Y to $144.49 million, beating the consensus of $141.75 million. The decline was driven primarily by... 
Via Benzinga
News headline image
Amarin: Q4 Earnings Insights ↗
Amarin Corp (NASDAQ:AMRN) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
News headline image
28 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... 
Via Benzinga
News headline image
51 Biggest Movers From Yesterday ↗
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
News headline image
NASDAQ: AMRN Investor Notice: Deadline on December 23, 2021in Lawsuit Against Amarin Corporation Plc ↗
San Diego, CA -- (SBWIRE) -- 12/16/2021 -- A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc (NASDAQ: AMRN). 
Via SBWire
News headline image
Why Amarin Stock Tumbled in November ↗
The biopharma's stock could be near a bottom after last month's double-digit decline. 
Via The Motley Fool
News headline image
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property Lawsuit
News headline image
LAWSUITS FILED AGAINST AMRN, CEI and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, AMRN and FB
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
Topics Intellectual Property Lawsuit
News headline image
CLASS ACTION UPDATE for BMRN, AMRN and Z: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Intellectual Property Lawsuit
News headline image
Lawsuits Filed Against AMRN, RECAF and HMLP - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
News headline image
CLASS ACTION UPDATE for INNV, ZEV and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Intellectual Property Lawsuit
News headline image
SHAREHOLDER ALERT: AMRN CEI SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMRN, HMLP and ONTF
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
Topics Initial Public Offering Intellectual Property Lawsuit
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and CEI
NEW YORK, NY / ACCESSWIRE / November 16, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.